Search
for
Sort by
Research 30 of 314
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride
- Bladder Cancer Survival of Men Receiving 5α-Reductase Inhibitors
- 5α-Reductase Inhibitors (5ARIs) and Male Reproduction
- 5-Alpha-Reductase Inhibitors and Combination Therapy
- Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.
- PCPT, MTOPS and the use of 5ARIs: a Canadian consensus regarding implications for clinical practice
- Upregulation of mir-1199-5p is associated with reduced type 2 5-α reductase expression in benign prostatic hyperplasia
- The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs).
- Risk of Depression after 5 Alpha Reductase Inhibitor Medication: Meta-Analysis
- The connection of 5-alpha reductase inhibitors to the development of depression
- Association Between 5-Alpha Reductase Inhibitor Use and The Risk of Depression: A Meta-Analysis.
- 5ARIs and PSA: Evidences
- Bladder cancer survival in men using 5-alpha-reductase inhibitors
- Effects of 5-alpha reductase inhibitors
- Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality
- 5ARI and PSA: open questions
- 5-alpha reductase inhibitors use in prostatic disease and beyond
- The relative effect of monotherapy with 5‐alpha reductase inhibitors and minoxidil for female pattern hair loss: A network meta‐analysis study
- FRI-02 FROM GIRLS TO BOYS TO OLDER MEN, THE INTERESTING TALE OF THE GUEVEDOCES AND 5-ALPHA REDUCTASE INHIBITORS
- The Risks and Benefits of 5α-Reductase Inhibitors for Prostate-Cancer Prevention
- Long-term use of 5α-reductase inhibitors and the risk of male breast cancer
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- Efficacy and safety of Finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia: A critical review of the literature
- Impact of Alpha Blockers, 5-alpha Reductase Inhibitors and Combination Therapy on Sexual Function
- Receipt of 5-Alpha Reductase Inhibitors Before Radical Cystectomy: Do They Render High-Grade Bladder Tumors Less Aggressive?
- 술 전 5-알파환원효소억제제의 투여가 120W Greenlight TM HPS 레이저를 이용한 광선택적 전립선기화술에 미치는 영향
- 5-Alpha Reductase Inhibitors in Prostate Cancer: From Clinical Trials to Clinical Practice
- Analysis of breast health outcomes in women on oral 5-alpha reductase inhibitors: A single-center retrospective cohort study
- Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors